Prostate Colon Current Events | Prostate Colon News | 10
|
| Page
10 of
39 |
771 Results |
|
|
|
Sort By:
Page Views | Date |
Estrogen study provides new impetus for development of colon cancer drugs
The female hormone estrogen may hold important clues for scientists working on new therapies for colon cancer, a study by Dana-Farber Cancer Institute researchers suggests. view more (2006-12-19)
Wheat bran can double the benefits of a high fibre diet in cancer prevention
The research team studied the intestinal and fecal contents of 24 pigs, because their digestive systems most closely resemble ours. The pigs were fed typical Western style diets, high in refined fats and sugars, and then either had their food supplemented with resistant starchsuch as that found in grains, corn, and potatoor wheat bran, or both. view more (1999-11-15)
Colon cancer survival linked to number of lymph nodes examined
An analysis of 17 studies from nine countries has found that the more lymph nodes that are removed and examined during surgical treatment of colon cancer, the better the outcome appears to be for patients. view more (2007-03-21)
UroGene and Pierre Fabre Médicament sign letter of intent
UroGene S.A. (Evry Génopole - France) and Pierre Fabre Médicament announced today the signature of a letter of intent for a three year collaboration to discover and develop new active compounds against a biological target identified by UroGene in advanced prostate cancer. This target is a cell surface protein which is elevated in... view more... (2002-01-28)
Botox: Its not just for wrinkles anymore
When researchers at the Chang Gung University Medical College, Taiwan and the University of Pittsburgh School of Medicine injected botulinum toxin A, or Botox, into the prostate gland of men with benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, they found that it eased symptoms and improved quality of life. view more (2006-05-24)
Common osteoporosis treatment may help men with prostate cancer suffering from bone loss
Men with prostate cancer who experience bone loss from cancer treatment could benefit from a weekly oral therapy commonly given to women with osteoporosis. view more (2006-02-27)
Study finds acceptable levels of anxiety among men living with early, untreated prostate cancer
Men with early stages of prostate cancer who delay radical treatment in favor of an approach of "expectant management" do not have high levels of anxiety and distress. view more (2009-07-27)
Overweight and obese men have lower PSA values, even before they get prostate cancer
Men who are overweight or obese have lower concentrations of prostate-specific antigen (PSA) in their blood than their normal-weight counterparts, according to a new study led by Duke University Medical Center researchers. view more (2008-02-20)
DEFINITIVE STUDY OF CANCER WAITING TIMES SUGGESTS MAJOR CHALLENGE FOR NHS
The paper, by Spurgeon, Barwell and Kerr at the University of Birmingham, will provide valuable baseline data which can be used to set targets for improvement in cancer services. The authors invited all English acute hospital trusts to submit data on new patients diagnosed with cancer during October 1997. They received data from 98 per cent of the... view more... (2000-03-13)
MDCT using dual energy setting may make CT colonography more 'patient-friendly'
MDCT performed with a dual energy setting may allow enhanced differentiation of polyps from fecal matter in an unprepped colon, meaning patients may be able to skip the uncomfortable colonic preparation before CT colonography. view more (2007-05-07)
NEW DIAGNOSTIC METHOD COULD IMPROVE DETECTION OF PROSTATE CANCER (p 1849)
A new diagnostic technique using colour Doppler with an ultrasound contrast agent is more effective than conventional systematic biopsy in diagnosing prostate cancer, conclude the authors of a research letter in this week's issue of THE LANCET. Prostate cancer detection is currently based on three diagnostic tests: serum prostate-specific antigen... view more... (2001-06-06)
Study raises questions about prostate cancer therapies targeting IGF-1
Therapies under development to treat prostate cancer by inhibiting the ability of insulin-like growth factor (IGF-1) to activate its target receptor could have unexpected results especially if a major tumor suppressor gene - p53 - is already compromised, according to new research by investigators at Fred Hutchinson Cancer Research Center. view more (2008-05-01)
No magic tomato? Study breaks link between lycopene and prostate cancer prevention
Tomatoes might be nutritious and tasty, but don't count on them to prevent prostate cancer. view more (2007-05-17)
OHSU Cancer Institute researcher identifies protein that helps predict prostate cancer survival
An Oregon Health & Science University Cancer Institute researcher has identified a protein that is a strong indicator of survival for men with advanced prostate cancer. The C-reactive protein, also known as CRP, is a special type of protein produced by the liver that is elevated in the presence of inflammation. view more (2008-04-23)
Apple pectin, apple juice extracts shown to have anticarcinogenic effects on colon
The apples and apple juice you consume may have positive effects in one of the most unlikely places in the body - in the colon. view more (2008-03-27)
Inside job: new radioactive agents for colon cancer work inside cells
Johns Hopkins scientists have developed a potentially novel way to fight colorectal cancer using tiny molecules to deliver potent barrages of radiation inside cancer cells, unlike current treatments that bind to the surface of cells and attack from the outside and cause unwanted side effects. view more (2007-10-10)
More than 6 months of hormone therapy doesn't help prostate cancer patients live longer
Prostate cancer patients treated with either radiation or surgery who use hormone therapy for longer than six months do not survive any longer than patients who use the treatment for a shorter amount of time. view more (2006-11-06)
Men with prostate cancer avoid radiation due to misconceptions
Negative perceptions about radiation therapy can strongly influence a prostate cancer patient's choice to avoid external beam radiation therapy, even though studies have proven the treatment to be as safe and effective as other treatments for the disease, including surgery. view more (2006-11-06)
Early results favorable for 5-day radiation treatment of early stage prostate cancer
Preliminary results show that a shortened course of radiation therapy for prostate cancer called stereotactic body radiation therapy (SBRT) provides good PSA response for early-stage prostate cancer and has the same side effects as other treatments. view more (2009-03-16)
Report: Prostate cancer screening has yet to prove its worth
The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small. view more (2009-06-29)
|
|
| Page
10 of
39 |
771 Results |
|
|
|
Sort By:
Page Views | Date |
|
